PROCEPT BioRobotics
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of PROCEPT BioRobotics generated cash of -$108,003,000, which is less than the previous year. Cash used in financing activities reached the amount of $167,795,000 last year. Net change in cash is therefore $34,586,000.

Cash Flow

PROCEPT BioRobotics Corporation (NASDAQ:PRCT): Cash Flow
2019 -43.81M 43.15M 26.52M
2020 -48.34M -233K 106.77M
2021 -57.33M -592K 262.11M
2022 -80.38M -2.65M 3.61M
2023 -108.00M -25.20M 167.79M

PRCT Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
225.67M305.09M100.90M42.71M16.85M
Operating activities
Net income
-105.89M-87.15M-59.85M-53.01M-41.97M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
3.80M2.84M3.32M2.86M1.49M
Stock-based compensation expense
19.13M10.33M3.79M2.17M1.99M
Deferred income tax benefit 19.13M10.33M3.79M2.17M1.99M
Changes in operating assets and liabilities:
Accounts receivable, net
-33.10M-10.80M-2.91M-511K522K
Inventories
-9.75M-15.25M-6.12M-3.10M-5.07M
Accounts payable
5.78M3.95M812K-205K-260K
Cash generated by operating activities
-108.00M-80.38M-57.33M-48.34M-43.81M
Investing activities
Purchases Of Investments
00000
Investments In Property Plant And Equipment
-25.20M-2.65M-592K-233K-7.61M
Acquisitions Net
00000
Cash generated by investing activities
-25.20M-2.65M-592K-233K43.15M
Financing activities
Common Stock Issued
161.70M6.41M262.11M82.08M1.99M
Payments for dividends
00000
Repurchases of common stock
02.40M000
Repayments of term debt
01.19M0-24.68M24.53M
Cash used in financing activities
167.79M3.61M262.11M106.77M26.52M
Net Change In Cash
34.58M-79.42M204.19M58.19M25.86M
Cash at end of period
260.26M225.67M305.09M100.90M42.71M
Data sourceData sourceData source